[67] studied a cohort of over 400,000 T2DM patients above the age of 65 and found that DPP-4i were associated with a 21% decrease in the risk of MACEs (including myocardial infarction and ischemic stroke) with a 46% overall decrease in risk of all-cause mortality
Dpcj.org
Rather than viewing weight loss in isolation, we see it as one element of a comprehensive wellness journey that addresses your body, your confidence, and your overall quality of life
The approval allows for earlier intervention and treatment with Rybelsus in adults with type 2 diabetes, when previously it was not approved as an initial (first-line) treatment option
Considerations & Potential Risks While the benefits are promising, GLP-1RA users have also reported some increased risks, including: Gastrointestinal issues (nausea, heartburn, abdominal pain, and gastroparesis)